Recruiting NCT03795376
Dat'Aids Prevention
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: HIV Prevention. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France, Guadeloupe, Martinique
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
HIV Prevention in France : "Dat'AIDS Prevention"
Overview
DatAIDS prevention is a cohort study of HIV prevention in over 23 HIV sites in France including overseas, aiming to describe HIV prevention in every aspect including HIV screening, STI and hepatitis screening, post-exposure prophylaxis and pre-exposure prophylaxis
Primary outcome measures
- Number of patients enrolled for HIV prevention in the cohort [Time frame: From date of enrollment, through study completion, an average of 1 year]
Secondary outcome measures (7)
- Proportion of persons enrolled for pre-exposure prophylaxis in the cohort [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Proportion of persons enrolled for post-exposure prophylaxis in the cohort [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Proportion of persons enrolled for hepatitis screening in the cohort [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Proportion of persons enrolled for pre-exposure prophylaxis in the cohort according to national French guidelines [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Proportion of persons enrolled for post-exposure prophylaxis in the cohort according to national French guidelines [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Incidence of STIs [Time frame: From date of enrollment, through study completion, an average of 1 year]
- Incidence of hepatitis [Time frame: From date of enrollment, through study completion, an average of 1 year]
Eligibility criteria
Inclusion criteria
- Male and female over 18 years old,
- HIV negative
- Attending for :
- HIV screening
- Hepatitis screening
- STI screening / treatment
- Blood, body fluid or sexual exposure
- Post-exposure prophylaxis
- Pre-exposure prophylaxis
- Signed consent
Exclusion criteria
- HIV-infection
- Refusal to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
France · 29 centers
- Hôpital Nord Franche Comté — Belfort
- CHU Besançon - Hôpital Jean Minjoz — Besançon
- CHRU Brest — Brest
- CHU Clermont-Ferrand - Hôpital Gabriel-Montpied — Clermont-Ferrand
- CHD Vendée — La Roche-sur-Yon
- Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris — Le Kremlin-Bicêtre
- CHU Limoges — Limoges
- Hôpital de la Croix-Rousse - Hospices Civils de Lyon — Lyon
- … and 21 more centers
Guadeloupe · 1 center
- CHU de Guadeloupe — Pointe-à-Pitre
Martinique · 1 center
- CHU de Martinique — Fort-de-France
Identifiers
NCT: NCT03795376 · DAT_002